// App-Quantinova.ai

4046 : Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer: Japan Clinical Oncology Group study (JCOG0501).

Researchers

Presenter

  • Yoshiaki Iwasaki

Principal Investigators

  • Junki Mizusawa

  • Hiroshi Katayama

  • Kenichi Nakamura

  • Hitoshi Katai

  • Takaki Yoshikawa

  • Yuichi Ito

  • Masahide Kaji

  • Yutaka Kimura

  • Motohiro Hirao

  • Makoto Yamada

  • Akira Kurita

  • Masakazu Takagi

  • Masahiro Gotoh

  • Akinori Takagane

  • Hiroshi Yabusaki

  • Naoki Hirabayashi

  • Takeshi Sano

  • Mitsuru Sasako

Medical Centers

  • Department of Surgery, IMS Tokyo-Katsushika General Hospital, Tokyo, Japan

  • Division of Gastric Surgery, Shizuoka Cancer Center, Nagaizumi, Japan

  • JCOG Data Center/ Operation Office, National Cancer Center Hospital, Tokyo, Japan

  • JCOG Data Center/ Operation Office, National Cancer Center Hospital, Tokyo, Japan

  • Japan Clinical Oncology Group Data Center, National Cancer Center, Tokyo, Japan

  • National Cancer Center Hospital, Tokyo, Japan

  • Kanagawa Cancer Center, Yokohama, Japan

  • Aichi Cancer Center Hospital, Nagoya, Japan

  • Toyama Prefectural Central Hospital, Toyama, Japan

  • Department of Surgery, Osaka Rosai Hospital, Sakai, Japan

  • Osaka National Hospital, Osaka, Japan

  • Department of Breast Surgery, Yamato Municipal Hospital, Yamato, Japan

  • Shikoku Cancer Center, Matsuyama, Japan

  • Shizuoka Cancer Center Hospital, Shizuoka, Japan

  • Osaka Medical College, Osaka, Japan

  • Hakodate Goryoukaku Hospital, Hakodate, Japan

  • Niigata Cancer Center Hospital, Niigata City, Japan

  • Department of Breast Surgery, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan

  • Japanese Foundation for Cancer Research Cancer Institute Hospital, Tokyo, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Cisplatin

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved